Phoebe Pelkey, PA-C

Phoebe Pelkey practices at Four Seasons Dermatology in Colchester, Vermont.

Phoebe Pelkey's NPI, 1811990104, was assigned on May 31, 2005. Phoebe Pelkey holds Vermont license 0550030608.

Phoebe Pelkey's primary practice is Four Seasons Dermatology, at 354 Mountain View Dr Ste 300 Suite 300, Colchester, VT 05446. The practice phone is (802) 864-0192.

Phoebe Pelkey's primary practice is Four Seasons Dermatology in Colchester, Vermont. The medical group on file is Four Seasons Dermatology. Dmand AI also links Phoebe Pelkey to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Phoebe Pelkey practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Phoebe Pelkey's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Phoebe Pelkey is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Phoebe Pelkey is licensed in Vermont.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and itchy rashes among the conditions Phoebe Pelkey treats.

CMS data shows 3,484 Medicare services from Phoebe Pelkey across 14 procedure codes in 2024, for 848 Medicare patients. Medicare paid $96,625 for them. Every service was in an office.

CMS counts 848 Medicare patients who saw Phoebe Pelkey in 2024. The largest group is 65 to 74, with 487 patients. 56% of them have high cholesterol, and 47% have high blood pressure. 3% are also on Medicaid. Their average risk score is 0.68, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Phoebe Pelkey's median patient age at 68, with 65% women.

In 2024, Phoebe Pelkey wrote 643 Medicare Part D claims for 311 patients. 88% of them were for generic drugs. CMS names the drug for 559 of them, across 16 drugs with 11 or more claims each, at $129,863 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Phoebe Pelkey for performance year 2024, reported as part of a group. Phoebe Pelkey accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Phoebe Pelkey from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Incyte Corporation paid the most, $28.

Phoebe Pelkey is a member of AAPA.